Stock listing

Rakovina Therapeutics Inc

Selected listing: A41APT · LS · EUR · DE

Rakovina Therapeutics Inc (Lang & Schwarz: A41APT), Finance. Latest release Oct 1, 2026: Rakovina Therapeutics Partners with Boston-based Celvion Therapeutics…

A41APT:LSEURDEUpdated October 2, 2026

Ticker: Lang & Schwarz: A41APT
Asset type: Stock
Sector: Finance
Industry: Financial Conglomerates
Exchange: Lang & Schwarz
Currency: EUR

Latest news from Rakovina Therapeutics Inc

Rakovina Therapeutics Partners with Boston-based Celvion Therapeutics to Leverage AI and Real-World Clinical Data for Precision Cancer Drug Development

October 1, 2026

Rakovina Therapeutics Announces Appointment of New Scientific Advisory Board Member

September 17, 2026

Rakovina Therapeutics Announces Appointment of Professor Petra Hamerlik to its Board of Directors

September 10, 2026

Rakovina Therapeutics Announces Q2 2026 Financial Results and Provides Corporate Update

August 31, 2026

Rakovina Therapeutics Announces Final Closing of Upsized Non-Brokered Private Placement

August 31, 2026

All Rakovina Therapeutics Inc news →

Research Rakovina Therapeutics Inc

Rakovina Therapeutics Inc company profile

View the public company page for Rakovina Therapeutics Inc on 6ix.

Rakovina Therapeutics Inc news

Read company news and market updates connected to Rakovina Therapeutics Inc.

Rakovina Therapeutics Inc investor events

Find investor webinars, events, and replay context for Rakovina Therapeutics Inc.